Contracts › 75A50325C00019
75A50325C00019: Relenza (ZANAMIVIR) Rotadisk, 5MG
Awarded to Glaxosmithkline, Llc by Office of Assistant Secretary for Preparedness and Response.
$45.5Mobligated
$63.7Mpotential value
29 September 2028current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75A50325C00019 |
|---|---|
| Awardee | Glaxosmithkline, Llc |
| Awarding agency | Office of Assistant Secretary for Preparedness and Response |
| Awarding office | ASPR/ORM-SNS |
| NAICS | 325412 Pharmaceutical Preparation Manufacturing |
| PSC | 6505 Drugs and Biologicals |
| Place of performance | NC |
| Offers received | 1 |
| Period of performance | 30 September 2025 to 29 September 2028 |
| Potential end | 29 September 2030 |
| Estimated recompete solicitation | ~Q2 2028 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 325412 contracts · All expiring contracts · USASpending record